Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marco Metra and Paolo Brambilla.
Marco Metra
Connection Strength
0.451
Paolo Brambilla
  1. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. 2020 Jun 05.
    View in: PubMed
    Score: 0.111
  2. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study. Arthritis Rheumatol. 2018 11; 70(11):1829-1834.
    View in: PubMed
    Score: 0.098
  3. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
    View in: PubMed
    Score: 0.055
  4. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol. 2018 Jul-Aug; 36 Suppl 113(4):68-75.
    View in: PubMed
    Score: 0.049
  5. Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2017 Nov-Dec; 35(6):1018-1028.
    View in: PubMed
    Score: 0.046
  6. Mapping and predicting mortality from systemic sclerosis. Ann Rheum Dis. 2017 11; 76(11):1897-1905.
    View in: PubMed
    Score: 0.046
  7. Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):114-121.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.